AIDA Survey

We are working on an AI tool to help detect gastric cancer early, but first, we need your views!

AIDA survey is anonymous, meaning no personal identifiers will be captured. All data will be pooled and analysed together.  

Please spread the word about the survey and help us develop an intelligent AI tool to detect cancer earlier!

The survey is available in multiple languages:

🇬🇧👉 https://digestivecancers.limesurvey.net/919165?lang=en

🇵🇹👉 https://digestivecancers.limesurvey.net/872374?lang=pt

🇳🇱👉 https://digestivecancers.limesurvey.net/415576?lang=nl

🇱🇻👉 https://digestivecancers.limesurvey.net/464112?lang=lv

🇱🇹👉https://digestivecancers.limesurvey.net/454558?lang=lt

🇫🇷👉 https://digestivecancers.limesurvey.net/165953?lang=fr

🇪🇸👉 https://digestivecancers.limesurvey.net/727798?lang=es

This survey is organised by Digestive Cancers Europe (DiCE) as part of the AIDA (Artificially Intelligent Diagnostic Assistant) project.

DiCE is an umbrella organisation representing nearly 40 national patient organisations across Europe. Our mission is to contribute to early diagnosis, decrease mortality from digestive cancers, and increase overall survival and quality of life. 

The AIDA project aims to develop and validate an artificial intelligence (AI) powered assistant that will support clinicians in gastric cancer prevention by diagnosing precancerous gastric inflammation and suggesting personalised therapeutics and monitoring.

Share

You might also be interested in

en

AIDA Publishes Major AI Breakthrough in Nature Communications

AIDA researchers have published a significant scientific advance in Nature Communications: an AI-powered “Clinician” capable of recommending personalised treatment for Helicobacter pylori (H. pylori), the leading cause of gastric cancer worldwide.

en

DiCE Hosts ENTERO Policy Event at the European Parliament

On April 24th, Digestive Cancers Europe (DiCE), a partner of the AIDA consortium, organised the ENTERO Policy Event at the European Parliament. The event brought together policymakers, clinicians, researchers, and patient advocates to highlight a growing concern in Europe: the rise of early-onset digestive cancers, including colorectal and gastric cancer.

events

AIDA General Assembly Meeting 2025

On the 24th and 25th of March, the AIDA Consortium gathered in London for the AIDA General Assembly 2025. Hosted by Imperial College London, the two-day meeting brought together leading experts and project partners to discuss the latest advancements in AI-driven gastric cancer research. The assembly commenced with a warm welcome from INCLIVA and Imperial College London, setting the stage